Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation

G Berkers; R van der Meer; P van Mourik; AM Vonk; E Kruisselbrink; SWF Suen; HGM Heijerman; CJ Majoor; GH Koppelman; J (Jolt) Roukema; Hettie Janssens; Yolanda de Rijke; EM Kemper; JM Beekman; CK van der Ent; Hugo de Jonge

doi:10.1016/j.jcf.2020.04.014

Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation

G Berkers
, R van der Meer
, P van Mourik
, AM Vonk
, E Kruisselbrink
, SWF Suen
, HGM Heijerman
, CJ Majoor
, GH Koppelman
, J (Jolt) Roukema
, Hettie Janssens
, Yolanda de Rijke
, EM Kemper
, JM Beekman
, CK van der Ent
, Hugo de Jonge

Research output: Contribution to journal › Article › Academic

15 Citations (Scopus)

Original language	English
Pages (from-to)	955-961
Number of pages	7
Journal	Journal of Cystic Fibrosis
Volume	19
Issue number	6
DOIs	https://doi.org/10.1016/j.jcf.2020.04.014
Publication status	Published - 2020

Research programs

EMC MM-04-20-01
EMC OR-01-54-02

Access to Document

10.1016/j.jcf.2020.04.014

http://hdl.handle.net/1765/127614

Cite this

Berkers, G., van der Meer, R., van Mourik, P., Vonk, AM., Kruisselbrink, E., Suen, SWF., Heijerman, HGM., Majoor, CJ., Koppelman, GH., Roukema, J., Janssens, H., de Rijke, Y., Kemper, EM., Beekman, JM., van der Ent, CK., & de Jonge, H. (2020). Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation. Journal of Cystic Fibrosis, 19(6), 955-961. https://doi.org/10.1016/j.jcf.2020.04.014

@article{e1bf6386116143acb3c9fd914a361fb7,

title = "Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation",

author = "G Berkers and \{van der Meer\}, R and \{van Mourik\}, P and AM Vonk and E Kruisselbrink and SWF Suen and HGM Heijerman and CJ Majoor and GH Koppelman and Roukema, \{J (Jolt)\} and Hettie Janssens and \{de Rijke\}, Yolanda and EM Kemper and JM Beekman and \{van der Ent\}, CK and \{de Jonge\}, Hugo",

year = "2020",

doi = "10.1016/j.jcf.2020.04.014",

language = "English",

volume = "19",

pages = "955--961",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier",

number = "6",

}

Berkers, G, van der Meer, R, van Mourik, P, Vonk, AM, Kruisselbrink, E, Suen, SWF, Heijerman, HGM, Majoor, CJ, Koppelman, GH, Roukema, J, Janssens, H, de Rijke, Y, Kemper, EM, Beekman, JM, van der Ent, CK & de Jonge, H 2020, 'Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation', Journal of Cystic Fibrosis, vol. 19, no. 6, pp. 955-961. https://doi.org/10.1016/j.jcf.2020.04.014

TY - JOUR

T1 - Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation

AU - Berkers, G

AU - van der Meer, R

AU - van Mourik, P

AU - Vonk, AM

AU - Kruisselbrink, E

AU - Suen, SWF

AU - Heijerman, HGM

AU - Majoor, CJ

AU - Koppelman, GH

AU - Roukema, J (Jolt)

AU - Janssens, Hettie

AU - de Rijke, Yolanda

AU - Kemper, EM

AU - Beekman, JM

AU - van der Ent, CK

AU - de Jonge, Hugo

PY - 2020

Y1 - 2020

U2 - 10.1016/j.jcf.2020.04.014

DO - 10.1016/j.jcf.2020.04.014

M3 - Article

SN - 1569-1993

VL - 19

SP - 955

EP - 961

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - 6

ER -